Back to Search
Start Over
94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11)
- Source :
-
Annals of Oncology . 2021 Supplement 7, Vol. 32, pS1415-S1415. 1p. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 153829397
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.10.112